Phase Ii Ilustro: 1l Zolbetuximab + Mfolfox6 + Nivolumab In Cldn18.2+ Mg/gej Cancer
Synopsis
Kohei Shitara, MD, National Cancer Center Hospital East, Kashiwa, Japan, discusses findings from the Phase II ILUSTRO trial ...
You Might Also Like
Download Options
Choose a download method below. All links open in new tabs.
| Service | Features | Action |
|---|---|---|
| SaveFrom |
MP4 & MP3 • HD Quality • Browser Extension Available
|
Download |
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.